Singapore markets close in 7 hours 47 minutes

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.5400+0.0400 (+2.67%)
At close: 02:40PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
Total revenue
74,077
79,660
52,432
25,363
Cost of revenue
37,451
37,655
22,990
10,380
Gross profit
36,626
42,005
29,442
14,983
Operating expenses
Research development
7,055
4,596
1,098
-
Selling general and administrative
44,392
36,172
28,934
15,615
Total operating expenses
51,888
41,274
30,482
15,664
Operating income or loss
-15,262
731
-1,041
-680.6943
Interest expense
11,666
9,819
6,442
2,904
Total other income/expenses net
12,629
-22,416
3,254
-1,295
Income before tax
-14,296
-31,501
-5,188
-4,719
Income tax expense
-6,214
-3,237
-790.4386
166.2867
Income from continuing operations
-8,082
-28,264
-4,397
-4,885
Net income
-8,082
-28,264
-4,397
-4,885
Net income available to common shareholders
-8,082
-28,264
-4,397
-4,885
Basic EPS
-
-1.86
-0.30
-0.49
Diluted EPS
-
-1.86
-0.30
-0.49
Basic average shares
-
15,197
14,360
9,909
Diluted average shares
-
15,197
14,360
9,909
EBITDA
-
-15,704
4,961
119.3342